{"originalText": "，缘于入院前[主诉单一时间1年于我院诊断“降结肠癌”，查无禁忌后，于2014年04月28日在全麻上行腹腔镜上右半结肠切除术。，术中见：无腹水，肝表面光滑，胃及空肠未见明显病变。降结肠可见一大约2*3CM隆起型肿物，质硬，侵出浆膜层，肠系膜根部未见明显肿大淋巴结，术顺，术后予抗炎、制酸、补液等对症治疗，，术后病理示：（结肠），：肠隆起型管状腺癌II级，侵及粘膜上层，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润；找到肠周淋巴结14个，及另送（肠系膜动脉根部）淋巴结2个，均未见癌转移。，免疫组化结果：KI67（40%阳性），P53（-），P170（+），GSTπ（+），EGFR（-），5-FU（++），MLH1（++），MSH6（++），MGMT（++）。该病例未检测到BRAF基因V600E突变、未检测到KRAS基因12、13号密码子热点突变。术后恢复良好。1周前患者于我院行PET-CT提示肝转移，无寒战、发热，无恶心、呕吐，无反酸、嗳气、腹胀、消瘦、头晕、乏力、皮肤巩膜黄染再次。就诊于我院，遂门诊拟降结肠癌术后收入院。自发病以来，精神、睡眠、食欲尚可，大便如下述，小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 25}, {"end_pos": 61, "label_type": "手术", "overlap": 0, "start_pos": 50}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 117}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 164, "end_pos": 175}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "影像检查", "overlap": 0, "start_pos": 395, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 404}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 459, "end_pos": 465}]}
